Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 14 March 1997:
Vol. 275. no. 5306, pp. 1615 - 0
DOI: 10.1126/science.275.5306.1615
Prev | Table of Contents | Next

Perspectives

Richard Gallagher

Two papers in the Journal of Experimental Medicine report the identification of a marker on the cell surface of T helper cells that can distinguish between the two main cell types, TH1 and TH2. This marker, the IL-12 receptor beta chain, will be useful for monitoring these important cell types, as well as providing a potential therapeutic target.

Science Magazine, Europe Office, Cambridge, UK.

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Interferon-{alpha} as an immunotherapeutic protein.
D. L. Brassard, M. J. Grace, and R. W. Bordens (2002)
J. Leukoc. Biol. 71, 565-581
   Abstract »    Full Text »    PDF »
T Cell Studies in a Peptide-Induced Model of Systemic Lupus Erythematosus.
M. Khalil, K. Inaba, R. Steinman, J. Ravetch, and B. Diamond (2001)
J. Immunol. 166, 1667-1674
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)